YOU & Song, Company, Inc. in Los Angeles inspected by FDA on Feb. 13, 2024

Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR)
Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) - Official Website
0Comments

On February 13, 2024, the Food and Drug Administration conducted an inspection at YOU & Song, Company, Inc. in Los Angeles, resulting in nine citations related to foodborne biological hazards, according to data posted on the FDA’s website.

The FDA website indicates that the citations were delivered to the company as follows:

  • ‘You did not take a reasonable measure or precaution related to personnel practices.’
  • ‘You did not keep the grounds around your plant in a condition that would protect against the contamination of food.’
  • ‘You did not maintain your plant in a clean and sanitary condition and in adequate repair.’
  • ‘You did not identify a toxic chemical in a manner that protects against contamination.’
  • ‘You did not exclude pests from your food plant to protect against contamination of food.’
  • ‘You did not clean and sanitize your utensils or equipment as frequently as necessary to protect against allergen cross-contact and contamination of food.’
  • ‘You did not clean your non-food contact surface in a manner and as frequently as necessary to protect against contamination.’
  • ‘Your equipment and utensils were not designed and constructed to be adequately cleaned or maintained to protect against allergen cross-contact and contamination.’
  • ‘You did not conduct operations under conditions and controls necessary to minimize the potential for growth or survival of microorganisms, contamination of food and deterioration of food.’

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Dr. Mehmet Oz CMS Administrator

Medicaid spending for surgery services in Monterey Park climbs 11.2% in 2024

Medicaid billings for the Surgery category increased by 11.2% in Monterey Park in 2024, highlighting shifts in care utilization and payment trends.

Dr. Mehmet Oz CMS Administrator

Alhambra Medicaid spending on anesthesia rises to $1,317,128 in 2024

Medicaid payments for anesthesia services in Alhambra surged 102.4% in 2024, reflecting shifts in how care is delivered and reimbursed.

Dr. Mehmet Oz CMS Administrator

West Hollywood Medicaid spending for Medicine Services and Procedures reaches $310,155 in 2024

Medicaid disbursements for the Medicine Services and Procedures category climbed 65.8% in 2024 in West Hollywood, highlighting shifts in both service usage and payment structures.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from LAX Leader.